EMA GMP in Advanced Therapy Medicinal Products (ATMPs)
EMA GMP in Advanced Therapy Medicinal Products (ATMPs) EMA’s GMP Framework for Advanced Therapy Medicinal Products (ATMPs) Advanced Therapy Medicinal Products (ATMPs) — including gene therapies, somatic cell therapies, and tissue-engineered products — represent one of the most innovative and complex sectors in modern medicine. Their highly personalized, high-risk nature requires tailored regulatory oversight. The…
Read More “EMA GMP in Advanced Therapy Medicinal Products (ATMPs)” »